Microfluidics-based point-of-care test for serodiagnosis of Lyme Disease

Currently, diagnostic testing for Lyme disease is done by determination of the serologic responses to Borrelia burgdorferi antigens, with the exception of the early localized phase of disease where diagnosis must be done clinically. Here, we describe the use of microfluidics technology to develop a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nayak, Samiksha, Sridhara, Archana, Melo, Rita, Richer, Luciana, Chee, Natalie H., Kim, Jiyoon, Linder, Vincent, Steinmiller, David, Sia, Samuel K., Gomes-Solecki, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057150/
https://www.ncbi.nlm.nih.gov/pubmed/27725740
http://dx.doi.org/10.1038/srep35069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057150/
https://www.ncbi.nlm.nih.gov/pubmed/27725740
http://dx.doi.org/10.1038/srep35069

Ejemplares similares